Novahue Vision*

Product | Clinical Studies

Discover how comprehensive clinical trials lead to the creation of this supplement and find out what it can do for your patients.

This product will not be available to ship until 7/1/2015
  • – Promotes retinal and macular health*
  • – Helps to support the transport of lutein to the eye*
  • – Works to offset the effects of ultraviolet rays and high energy visible light*
  • – Provides high potency antioxidants vitamins C & E as well as zinc*

read more

Clinical Studies

In Vivo and Ex Vivo Formulation Study

The effect of carotenoids and carnosic acid on inflammation.

The combination of lutein, lycopene, and carnosic acid was found to interfere with key molecular processes responsible for the production of proinflammatory mediators and cytokines in stimulated macrophages. Additionally, the production of pro-inflammatory mediator TNFα was inhibited after mouse peritoneal macrophages were pre-incubated for 24 hours with those same ingredients.

Clinical Study Prostate Chart

N. Hadad and R. Levy, 2012. The synergistic anti-inflammatory effects of lycopene, lutein, betacarotene,
and carnosiuc acid combinations via redoxc- based inhibition of NF-kappa ß signaling. Free
Radic Biol Med. 53:1381-1391.

In Vivo and In Vitro Studies on Carnosic Acid

Protective effect of carnosic acid in models of oxidative
stress and light damage2

Multiple studies have demonstrated the antioxidant and neuroprotective activity of carnosic acid in the retina. Research suggests that this nutrient’s ability to penetrate the blood/brain barrier allows it to reach the eye and protect the outer retina from oxidative stress.

Clinical Study Prostate Chart

2. Rezaie, T. et al., 2012. Protective effect of carnosic acid, a pro-electrophilic compound, in models of
oxidative stress and light-induced retinal degeneration. Invest Ophthalmol Vis Sci, 53: 7847-7854.
3. Yanagitai, M. et al., 2012. Carnosic acid, a pro-electrophilic compound, inhibits LPS-induced activation
of microglia. Biochem Biophys Res Commun, 418: 22-26.
4. Satoh, T. et al., 2008. Carnosic acid, catechol-type electrophilic compound, protects neurons both in
vitro and in vivo through activation of the Keap1/ Nrf2 pathway via S-alkylation of targeted cysteines
on Keap1. J Neurochem, 104: 1116-1131.

The statements on this site have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease.